Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

<p><strong>Background</strong> There have been no studies of the patterns of post-marketing withdrawals of medicinal products to which adverse reactions have been attributed. We identified medicinal products that were withdrawn because of adverse drug reactions, examined the eviden...

Descripció completa

Dades bibliogràfiques
Autors principals:	Onakpoya, IJ, Heneghan, CJ, Aronson, JK
Format:	Journal article
Idioma:	English
Publicat:	BioMed Central 2016

Ítems similars

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
per: Igho J. Onakpoya, et al.
Publicat: (2019-03-01)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
per: Onakpoya, I, et al.
Publicat: (2016)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
per: Onakpoya, I, et al.
Publicat: (2017)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
per: Onakpoya, I, et al.
Publicat: (2016)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
per: Onakpoya, I, et al.
Publicat: (2017)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
per: Onakpoya, I
Publicat: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
per: Onakpoya, I, et al.
Publicat: (2017)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
per: Onakpoya, IJ, et al.
Publicat: (2020)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
per: Daniele Sartori, et al.
Publicat: (2020-08-01)

Withdrawal of cerivastatin from the world market
per: Pitt Bertram, et al.
Publicat: (2001-09-01)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
per: Onakpoya, I, et al.
Publicat: (2018)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
per: Aronson, J
Publicat: (2017)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
per: Aronson, J
Publicat: (2008)

Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals: a systematic review update
per: Jefferson, T, et al.
Publicat: (2022)

An agenda for research on adverse drug reactions.
per: Aronson, J
Publicat: (2007)

Adverse drug reactions--no farewell to harms.
per: Aronson, J
Publicat: (2007)

Pharmacogenetics and adverse drug reactions
per: Ferner, R, et al.
Publicat: (2010)

REG 462 - Rekabentuk Konkrit
per: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Publicat: (1995)

Withdrawn medicines included in the essential medicines lists of 136 countries.
per: Onella Charles, et al.
Publicat: (2019-01-01)

Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis: a systematic review
per: Salas-Gama, K, et al.
Publicat: (2022)

20.462J / 3.962J Molecular Principles of Biomaterials (BE.462J), Spring 2003
per: Irvine, Darrell J.
Publicat: (2003)

The effectiveness and safety of Japanese traditional medicine (Kampo) in the treatment of climacteric symptoms
per: Onakpoya, I, et al.
Publicat: (2013)

Adverse drug reactions: definitions, diagnosis, and management.
per: Edwards, I, et al.
Publicat: (2000)

What evidence affects clinical practice? An analysis of Evidence-Based Medicine commentaries
per: Coombs, C, et al.
Publicat: (2017)

Spontaneous reporting to regulatory authorities of suspected adverse drug reactions to COVID-19 vaccines over time: the effect of publicity
per: Ferner, RE, et al.
Publicat: (2022)

Adverse drug reactions: keeping up to date.
per: Aronson, J, et al.
Publicat: (2002)

Is It Because I Can or Because of Who I Am?
per: María Laura Gonzalez-Canosa, et al.
Publicat: (2021-12-01)

Paradoxical reactions: Under-recognized adverse effects of drugs?
per: Hauben, M, et al.
Publicat: (2006)

National differences in publishing papers on adverse drug reactions.
per: Ferner, R, et al.
Publicat: (2005)

RMK462 - PENTADBIRAN TANAH FEBRUARI 1998
per: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Publicat: (1998)

REG 462 - REKABENTUK KONKRIT JUN 1992
per: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Publicat: (1992)

PGT 462: Pengelolaan Dan Penyelidikan Sekolah
per: PPIP, Pusat Pengajian Ilmu Pendidikan
Publicat: (1997)

PGT 462 Pengelolaan dan Penyeliaan Sekolah
per: PPIP, Pusat Pengajian Ilmu Pendidikan
Publicat: (1997)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
per: Aronson, J
Publicat: (2012)

Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993–2016
per: Johanna Seifert, et al.
Publicat: (2024-11-01)

The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
per: Łukasz Dobrek
Publicat: (2022-08-01)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
per: Talbot, J, et al.
Publicat: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
per: Talbot, J, et al.
Publicat: (2012)

SARS-CoV-2 and the role of orofecal transmission: a systematic review
per: Heneghan, CJ, et al.
Publicat: (2021)

SARS-CoV-2 and the role of fomite transmission: a systematic review
per: Onakpoya, IJ, et al.
Publicat: (2021)